Figures computed from official regulatory filings — methodology.
| Insider | Type | Value · USD | |
|---|---|---|---|
| NOVARTIS PHARMA AG | Other | $816.4M | SEC |
| KLARMAN SETH A | Other | $1.3B | SEC |
| Beckman Daniella | OtherD | $0 | SEC |
| Mayers Douglas L | OtherD | $0 | SEC |
| Renaud Ronald C JR | OtherD | $0 | SEC |
| Pollard-Knight Denise | OtherD | $0 | SEC |
| Fanning Paul | OtherD | $0 | SEC |
| Fanning Paul | OtherD | $0 | SEC |
| Renaud Ronald C JR | OtherD | $0 | SEC |
| Beckman Daniella | OtherD | $0 | SEC |
| Pollard-Knight Denise | OtherD | $0 | SEC |
| Mayers Douglas L | OtherD | $0 | SEC |
| Pollard-Knight Denise | OtherD | $0 | SEC |
| Stahl Maria D | OtherD | $0 | SEC |
| HOWSON TAMAR D | OtherD | $0 | SEC |
| Rowland Charles A Jr | OtherD | $0 | SEC |
| HODGSON THOMAS R | OtherD | $0 | SEC |
| HOCKMEYER WAYNE T | OtherD | $0 | SEC |
| HOCKMEYER WAYNE T | OtherD | $0 | SEC |
| Mayers Douglas L | OtherD | $0 | SEC |
| Fanning Paul | OtherD | $0 | SEC |
| Stahl Maria D | OtherD | $0 | SEC |
| Fanning Paul | OtherD | $0 | SEC |
| HODGSON THOMAS R | OtherD | $0 | SEC |
| HODGSON THOMAS R | OtherD | $0 | SEC |